Glenmark Pharmaceuticals
GLENMARK.NS
#2749
Rank
A$7.35 B
Marketcap
$26.06
Share price
0.59%
Change (1 day)
36.27%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): $0.17

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.17. In 2022 the company made an earnings per share (EPS) of $0.61 a decrease over its 2021 EPS that were of $0.76.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.17-72.41%
2022$0.61-20.18%
2021$0.767.13%
2020$0.7125.72%
2019$0.57-22.01%
2018$0.7330.15%
2017$0.56-34.82%
2016$0.8663.09%
2015$0.529.68%
2014$0.48-26.58%
2013$0.650.51%
2012$0.65